Losartan Eye Drops | Ophthalmic Solution

Losartan eye drops compounded for ophthalmic use in corneal scarring management

Losartan Potassium 0.8 mg/mL Ophthalmic Solution

Losartan Eye Drops

Sterile and Preservative-Free
Quantity:
8 mL
Price: $70 + shipping. Login to the Practitioner Portal for all ophthalmic compound pricing. 

Sig:
1 drop in affected eye(s) 4–6 times daily

Sterile compounded ophthalmic preparation available by prescription. The FDA does not review any compounded medication for safety or efficacy. 

What is Losartan Ophthalmic Solution?

Losartan ophthalmic solution is an emerging compounded therapy being explored by ophthalmologists for the management of corneal scarring and fibrosis-related ocular conditions, particularly following injury, infection, or surgery.

At Massey Drugs, we compound preservative-free losartan eye drops in our sterile compounding laboratory for ophthalmologists evaluating emerging, non-steroidal approaches to corneal fibrosis.

Losartan is an angiotensin II receptor blocker (ARB) widely used orally for hypertension and renal disease. When taken systemically, only negligible amounts reach ocular tissues. However, when compounded as a topical ophthalmic solution, losartan is being studied for its anti-fibrotic effects in the cornea.

Topical losartan eye drops are not commercially available and must be prepared by a compounding pharmacy with sterile ophthalmic capabilities.

What is the Mechanism of Action in the Cornea?

Corneal scarring is driven in part by the transformation of keratocytes into myofibroblasts, which produce disorganized collagen and permanent stromal opacity.

Preclinical research suggests that topical losartan may influence corneal fibrosis through several mechanisms, including:

  • Interfere with TGF-β signaling

  • Inhibit myofibroblast formation

  • Reduce abnormal collagen deposition

  • Potentially reduce fibrotic changes during corneal healing

These proposed anti-fibrotic mechanisms have generated interest in topical losartan as a potential treatment approach for corneal scarring. Additional clinical research is needed to establish its safety and effectiveness.

Clinical Scenarios Where Ophthalmologists Explore Topical Losartan

Ophthalmologists may explore compounded losartan eye drops in clinical scenarios involving corneal fibrosis or stromal scarring, including:

  • Keratoconus with corneal scarring or stromal fibrosis
  • Post-surgical corneal haze or scarring
  • Traumatic corneal injuries
  • Microbial keratitis with residual stromal scarring
  • Persistent corneal epithelial defects
  • Chemical or thermal corneal burns

These scenarios represent areas of clinical interest and investigation, not established indications for topical losartan. Treatment decisions should be based on the individual patient’s condition and the prescribing ophthalmologist’s clinical judgment.

Preservative-Free Ophthalmic Compounding

Preservative Free Formulation

All losartan eye drops compounded at Massey Drugs are prepared as preservative-free ophthalmic solutions, designed to minimize:

  • Ocular surface toxicity

  • Preservative-related inflammation

  • Irritation with frequent dosing

Preservative-free formulations are particularly important in patients requiring multiple daily administrations or those with compromised corneal surfaces.

Why Ophthalmologists Choose Massey Drugs

  • Sterile compounding laboratory experienced in ophthalmic preparations
  • Preservative-free formulations tailored for ocular use
  • Direct pharmacist access for clinical questions
  • Medication typically ships within 24–48 hours after patient address confirmation and payment.
  • Experience working with corneal specialists and surgical practices
  • NABP Accredited Compounding Pharmacy

States We Serve

States where Massey Drugs ships compounded medications.

Massey Drugs is licensed to dispense and ship prescription compounded medications to patients in 16 states: Alabama, Mississippi, Tennessee, Texas, Louisiana, Florida, Georgia, Kentucky, Indiana, Illinois, Ohio, Pennsylvania, New York, Connecticut, North Carolina, and South Carolina.

Ophthalmologists and other licensed prescribers in these states can work directly with Massey Drugs to prescribe patient-specific compounded ophthalmic medications, including Losartan Eye Drops.

How to Prescribe Losartan Eye Drops

Download a Prescription Form from the Practitioner Portal and send to Massey Drugs:

FAX: 800.637.2601
Phone: 833.540.3500
OR

e-Scribe: NPI#: 1295756245 | NCPDP#: 0127553
Massey Drugs | Cloverdale Road 

Upon receipt of prescription, Massey Drugs contacts the patient to confirm shipping address and credit card payment. 

Medication typically ships within 24–48 hours after the patient’s shipping address is confirmed and payment is received.

Massey Drugs provides competitively priced compounded ophthalmic eye drops with transparent, prescriber-accessible pricing. All compound pricing can be viewed in our Practitioner Portal so costs can be communicated to patients before prescribing.

Speak with a Pharmacist

If you have questions about losartan ophthalmic compounding, formulation options, or whether this therapy may be appropriate for a specific clinical scenario, our pharmacists are available to consult. Call 833-540-3500 or contact us.

Frequently Asked Questions

Can losartan eye drops be used after corneal surgery or injury?

In some clinical settings, ophthalmologists may consider topical losartan following corneal procedures or injuries associated with stromal fibrosis or haze. Timing and appropriateness depend on factors such as epithelial healing status, infection risk, and the underlying cause of corneal scarring. Treatment decisions should be individualized based on slit-lamp findings and visual impact.

Emerging clinical experience suggests that losartan may be most helpful in corneal haze or fibrosis driven by myofibroblast activity rather than surface irregularity alone. In cases where significant structural irregularity is present, surgical smoothing procedures may be considered before or alongside medical therapy. (Cleveland Clinic)

Losartan ophthalmic solution is often incorporated into broader treatment plans that may include anti-inflammatory agents, antibiotics, lubrication, or nutritional support depending on the etiology of the corneal condition. Combination therapy may help address multiple pathways involved in corneal healing and fibrosis.

Ophthalmologists commonly monitor visual acuity trends, glare symptoms, and slit-lamp findings such as scar density or depth. Serial photography or corneal imaging may also be used to track fibrosis changes and guide treatment duration or adjustments.

If there is minimal clinical response after an adequate trial period, physicians may reassess the diagnosis, optimize adjunctive therapies, or consider procedural interventions such as phototherapeutic keratectomy or corneal transplantation in more advanced cases.

Ophthalmologists can prescribe Massey Drugs’ preservative-free Losartan Potassium 0.8 mg/mL Ophthalmic Solution through e-prescribing or by submitting a prescription using the Practitioner Portal. The 8 mL formulation is $70 plus shipping. For prescribing assistance or formulation questions, contact Massey Drugs at 833.540.3500.

References

The following references are provided for clinical background and educational purposes.

Additional Ophthalmic Compounding Capabilities

We compound additional sterile ophthalmic therapies used for: 

  • Post-operative Care
  • Emergency & Infection Management
  • Emergency & Corneal Scarring Support
  • Glaucoma Compounding
  • Myopia Management

Explore our full range of ophthalmic compounding capabilities.